Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

Researchers at Weill Cornell Medicine identified a mechanism by which ovarian tumors inhibit T cell lipid uptake, impairing ...

Both agreed that there have been no trials directly comparing a BsAb therapy vs CAR T cells, so there is no definitive answer, and Landsburg was reluctant to take a hard line on reserving BsAbs until ...

This approach collects a patient's T cells, engineers them to attack tumor cells and then injects the designer cells into the ...

“Lyell’s vision is to bring meaningful and durable clinical benefit to patients suffering from cancer with our ...

This approach collects a patient's T cells, engineers them to attack tumor cells and then injects the designer cells into the patient. "CAR T cells work well against hematological cancers like ...

Lymphoma, a cancer of the immune system, is silently ravaging the health of Black men across America. This insidious disease, ...

Called CAR-T cell therapy, the treatment involves taking the patient's immune cells or T-cells and genetically altering them ...

2015 年至今，细胞出版社已经成功连续举办了九届中国科学家与 Cell Press 活动，在过去的 2023 年里，中国科研工作者在 Cell Press ...

The deal will give Lyell a dual-targeting CAR-T candidate for blood cancers. Relatedly, Lyell will also end development of ...

A laboratory that will deliver ‘home-grown’ CAR-T cells to improve treatment for blood cancers is to open at Addenbrooke’s ...

Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that the first patients have been dosed in an ...